A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

Clinical trial NCT00046111 · COMPLETED

Trial details

NCT number: NCT00046111
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer, Small Cell Solid Tumor Cancer

Start date: 2001-09-01
Primary completion: 2004-04-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.